The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers who have significant controls over the individuals in focus are always inapplicable. The offspring entities and appointments are those entities that the individuals in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Inapplicable
parent relation
Individuals in focus

Mccurry, Kevin Joseph

    Related profiles found in government register
  • Mccurry, Kevin Joseph
    American chief strategic officer born in April 1967

    Resident in United States

    Registered addresses and corresponding companies
    • 3, More London Riverside, London, SE1 2AQ, England

      IIF 1
    • C/o Evaluate Limited, 3 More London Riverside, London, SE1 2AQ, United Kingdom

      IIF 2
  • Mccurry, Kevin Joseph
    American chief strategy officer born in April 1967

    Resident in United States

    Registered addresses and corresponding companies
child relation
Offspring entities and appointments
Active 9
  • 1
    OPIO BIDCO LIMITED - 2016-11-22
    C/o Evaluate Limited, 3 More London Riverside, London, United Kingdom
    Corporate (3 parents, 1 offspring)
    Profit/Loss (Company account)
    -23,296,000 GBP2023-01-01 ~ 2023-12-31
    Officer
    2025-02-04 ~ now
    IIF 4 - director → ME
  • 2
    EVALUATEPHARMA LIMITED - 2012-11-19
    EVALUATE LIMITED - 2012-10-25
    EVALUATE PLC - 2007-08-23
    C/o Evaluate Limited, 3 More London Riverside, London, United Kingdom
    Corporate (3 parents, 5 offsprings)
    Equity (Company account)
    141,000 GBP2023-12-31
    Officer
    2025-02-04 ~ now
    IIF 6 - director → ME
  • 3
    OPIO HOLDCO LIMITED - 2016-11-22
    C/o Evaluate Limited, 3 More London Riverside, London, United Kingdom
    Corporate (3 parents, 1 offspring)
    Equity (Company account)
    -356,000 GBP2023-12-31
    Officer
    2025-02-04 ~ now
    IIF 8 - director → ME
  • 4
    EVALUATEPHARMA LIMITED - 2012-10-25
    3 More London Riverside, London, United Kingdom
    Corporate (3 parents)
    Equity (Company account)
    16,584,000 GBP2023-12-31
    Officer
    2025-02-04 ~ now
    IIF 3 - director → ME
  • 5
    OPIO TOPCO LIMITED - 2016-11-22
    C/o Evaluate Limited, 3 More London Riverside, London, United Kingdom
    Corporate (3 parents, 1 offspring)
    Equity (Company account)
    1,487,000 GBP2023-12-31
    Officer
    2025-02-04 ~ now
    IIF 9 - director → ME
  • 6
    3 More London Riverside, London, England
    Corporate (3 parents)
    Equity (Company account)
    2,081,752 GBP2023-12-31
    Officer
    2025-02-04 ~ now
    IIF 1 - director → ME
  • 7
    C/o Evaluate Limited, 3 More London Riverside, London, United Kingdom
    Corporate (3 parents, 2 offsprings)
    Profit/Loss (Company account)
    -193,234,000 GBP2023-01-01 ~ 2023-12-31
    Officer
    2025-02-04 ~ now
    IIF 2 - director → ME
  • 8
    C/o Evaluate Limited, 3 More London Riverside, London, United Kingdom
    Corporate (3 parents, 1 offspring)
    Equity (Company account)
    1,140,000 GBP2022-12-31
    Officer
    2025-02-04 ~ now
    IIF 5 - director → ME
  • 9
    C/o Evaluate Limited, 3 More London Riverside, London, United Kingdom
    Corporate (3 parents, 1 offspring)
    Equity (Company account)
    168,969,000 GBP2022-12-31
    Officer
    2025-02-04 ~ now
    IIF 7 - director → ME
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.